The following represents disclosure information provided by authors of this abstract. The Gastrointestinal Cancers Symposium Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
The safety of chemotherapy for colorectal cancer patients with hepatitis C virus infection.
Kenji Tomizawa
No relevant relationships to disclose
Koichi Suyama
No relevant relationships to disclose
Yuji Miura
No relevant relationships to disclose
Akihiko Shimomura
No relevant relationships to disclose
Yutaka Hanaoka
No relevant relationships to disclose
Shigeo Toda
No relevant relationships to disclose
Jin Moriyama
No relevant relationships to disclose
Shuichiro Matoba
No relevant relationships to disclose
Toshimi Takano
No relevant relationships to disclose
Hiroya Kuroyanagi
No relevant relationships to disclose